Result Summaries: Hepatitis A Inactivated and Hepatitis B Recombinant Vaccine
| GSK Study ID |
Phase | Title | Summary (Download) |
|---|---|---|---|
| 100386 - 100387 | Phase 3 | Phase III, open, randomised study, in two centres, to demonstrate the equivalence of the 0-12 month schedule to the 0-6 month schedule with respect to the immunogenicity and to evaluate the safety and reactogenicity of GSK Bios’ Twinrix™ Adult vaccine in healthy volunteers aged from 12 to 15 years (1 citation(s)) |  |